Trade News Brief: Section 301 Tariff Litigation, Pharmaceutical Trade Measures, and U.S. Market Update (September 24, 2026) – KITA Trade Newsline Issue No. 2026-19

The latest Trade Newsline from KITA Dallas Center reviews major U.S. trade and market developments, including legal challenges to Section 301 forced-labor tariffs, U.S. labor-market conditions, pharmaceutical trade measures, and other policy and industry developments affecting Korean companies.

This issue is particularly relevant for companies monitoring U.S. tariff litigation, customs and compliance risk, pharmaceutical market access, workforce conditions, and supply-chain planning in the United States.

Key Highlights

•  Legal challenges to U.S. Section 301 forced-labor tariffs affecting imports from major trading partners

•  Questions surrounding the scope and legal process for the 10% to 12.5% forced-labor tariff measures

•  Upcoming U.S. Court of International Trade proceedings and their potential implications for importers

•  U.S. labor-market and hiring conditions and related economic indicators

•  Pharmaceutical trade-policy developments as new U.S. tariff measures move toward implementation

•  Implications for Korean pharmaceutical and life-sciences companies, including product classification, tariff treatment, and U.S. production strategy

•  Additional U.S. trade, industry, and supply-chain news relevant to Korean businesses

•  Expert commentary on practical issues facing companies operating in the United States

•  Market snapshot including major equity, interest-rate, oil-price, and exchange-rate indicators

•  KITA Dallas Center programs, events, and local business-support resources

Source: KITA Dallas Center – Trade Newsline, Issue No. 2026-19

View the full newsletter: KITA Trade Newsline Issue No. 2026-19

한국어 요약

KITA 달라스 센터의 Trade Newsline Issue No. 2026-19에서는 미국 무역법 301조 강제노동 관세 관련 소송, 미국 노동시장 동향, 의약품 통상조치, 한국 기업에 영향을 줄 수 있는 주요 정책·산업 뉴스를 정리했습니다.

미국 시장에서 사업을 운영하는 한국 기업에게는 관세 소송과 통관 리스크, 의약품 시장 접근, 인력시장 변화, 공급망 전략을 함께 점검할 수 있는 자료입니다.

주요 내용

•  주요 교역국 수입품에 적용되는 미국 무역법 301조 강제노동 관세 관련 법적 분쟁

•  10~12.5% 강제노동 관세의 적용 범위 및 절차적 쟁점

•  미국 국제무역법원(CIT) 절차와 수입기업에 미칠 수 있는 영향

•  미국 노동시장·채용 동향 및 관련 경제지표

•  새로운 미국 관세조치 시행을 앞둔 의약품 통상정책 동향

•  품목 분류, 관세 적용 및 미국 생산전략과 관련한 한국 제약·바이오 기업의 시사점

•  한국 기업이 참고할 미국 통상·산업·공급망 관련 뉴스

•  미국에서 사업하는 기업을 위한 실무 이슈 전문가 칼럼

•  주요 주가, 금리, 국제유가 및 환율 지표

•  KITA 달라스지부 사업, 행사 및 현지 지원 서비스 안내

뉴스레터 전문 보기: KITA Trade Newsline Issue No. 2026-19